Antioxidant, Lipid Lowering, and Membrane Stabilization Effect of Sesamol against Doxorubicin-Induced Cardiomyopathy in Experimental Rats

Table 1

Effect of sesamol on serum TCH, TGL, LDL, VLDL, and HDL.

Group	TGL (mg/dL)	TCH (mg/dL)	LDL (mg/dL)	VLDL (mg/dL)	HDL (mg/dL)
G1: control	103.0±5.8	103.0±1.7	51.5±2.2	20.5±0.76	26.3±0.42
G2: sesamol (50 mg/kg)	105.0±2.2	110.8±2.9	56.0±3.2	19.5±0.76	27.5±0.76
G3: DOX (15 mg/kg in 6-divided dose)	169.0±4.4^a	131.3±3.4^a	73.5±2.2^a	28.0±3.2^a	19.0±3.0^a
G4: DOX+sesamol	79.00±2.2^b	110.0±2.0^b	62.5±0.76^b	20.5±0.76^b	27.6±0.42^b

All values expressed as mean ± SEM. ^a𝑃<0.05 versus G1. ^b𝑃<0.05 versus G3.